scholarly article | Q13442814 |
P50 | author | Ana Paula Junqueira-Kipnis | Q88924392 |
André Kipnis | Q38326075 | ||
P2093 | author name string | Adriana Oliveira Guilarde | |
Maria Cláudia Porfirio André | |||
Cássia Silva de Miranda Godoy | |||
Juliana Lamaro Cardoso | |||
Suellen Rocha Araújo Castilho | |||
P2860 | cites work | Defining bacterial species in the genomic era: insights from the genus Acinetobacter | Q21558549 |
Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen | Q26766333 | ||
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections | Q26991886 | ||
Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
DNA fingerprinting of Mycobacterium tuberculosis | Q28246457 | ||
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 | ||
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). | Q50940090 | ||
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. | Q54606682 | ||
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain | Q58387204 | ||
United Nations meeting on antimicrobial resistance | Q59872582 | ||
Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil | Q84575252 | ||
Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea | Q33859045 | ||
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines | Q33970910 | ||
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii | Q34042171 | ||
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia | Q34042432 | ||
Biofilm formation by clinical isolates and the implications in chronic infections | Q34565318 | ||
AcinetobacterOutbreaks, 1977–2000 | Q35119005 | ||
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil | Q35155708 | ||
Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature. | Q35543456 | ||
Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
OXA-type carbapenemases | Q36381840 | ||
The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 | ||
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. | Q37119524 | ||
First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern Brazil | Q37160172 | ||
Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands | Q37263415 | ||
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis | Q37523948 | ||
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species | Q38471963 | ||
Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran | Q39475956 | ||
Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil | Q39639656 | ||
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces | Q40051413 | ||
Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability | Q40741659 | ||
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii | Q41833657 | ||
Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia | Q42233930 | ||
Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge | Q43171435 | ||
Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients | Q43472439 | ||
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199 | Q43587149 | ||
Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil | Q43598708 | ||
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program | Q45027537 | ||
Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. | Q46552025 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Brazil | Q155 |
Acinetobacter baumannii | Q3241189 | ||
intensive care unit | Q5094647 | ||
P304 | page(s) | e0176790 | |
P577 | publication date | 2017-05-05 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles | |
P478 | volume | 12 |
Q60929371 | A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit |
Q93032648 | Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant Acinetobacter baumannii |
Q64892239 | Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii. |
Q61799375 | Metabolic Responses to Polymyxin Treatment in ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling |
Q58753601 | Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species |
Q91877872 | Prevalence and antibiotic resistance of Acinetobacter baumannii among patients in postcardiac surgery intensive care units of Rajaei Hospital, Tehran |
Q91964359 | Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients |
Search more.